According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
Behind Every Blood Test, a Step Forward in Care
When a doctor is waiting for a blood test result, what happens inside the laboratory matters. Each stage, from processing a sample to reviewing its findings, helps shape the next decision in a patient’s care.
Turning Clinical Insights into Better Patient Outcomes
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
55fda2dc551e4ff68748a1aabe8694a6.jpg?sfvrsn=a1e3ed8c_1)
